Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Bladder Cancer

Free Subscription 29.04.2024 1 Aging (Albany NY) 1 Arch Med Res 1 Arch Pathol Lab Med 1 Arch Toxicol 1 Biochem Genet 1 BJU Int 1 BMC Urol 1 Cell Death Dis 2 Cells 1 Curr Issues Mol Biol 1 Curr Oncol 1 Curr Opin Urol 1 Cytometry A 2 Discov Oncol 1 Eur J Nucl Med Mol Imaging 1 Eur Urol Focus 1 Eur Urol Oncol 1 Exp Cell Res 1 Front Cell Infect Microbiol 1 Int Immunopharmacol 3 Int J Clin Oncol 1 Int J Med Inform 1 Int J Surg 1 Int Med Case Rep J 1 Int Urogynecol J 1 J Am Anim Hosp Assoc 1 J Clin Pathol 1 J Clin Transl Sci 1 J Med Econ 1 J Urol 1 Jpn J Clin Oncol 1 Kidney Int 1 Lasers Surg Med 1 Medicine (Baltimore) 1 Mol Biotechnol 1 Nat Rev Clin Oncol 1 Nat Rev Urol 1 Oncol Lett 1 Res Sq 1 Sci Rep 1 Small 1 Technol Cancer Res Treat 1 Transl Oncol 3 Urol Oncol 2 Urology 1 World J Urol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Aging (Albany NY)

1. LI Y, Jiang C, Liu Q, Zhou P, et al
   USP15 facilitates the progression of bladder cancer by amplifying the activation of the NF-kappaB signaling pathway.
   Aging (Albany NY). 2024;16.
   PubMed         Abstract available
   
   

   
   Arch Med Res

2. MOHAMED AS, Salama AF, Sabaa MA, Toraih E, et al
   GEMIN4 Variants: Risk Profiling, Bioinformatics, and Dynamic Simulations Uncover Susceptibility to Bladder Carcinoma.
   Arch Med Res. 2024;55:102970.
   PubMed         Abstract available
   
   

   
   Arch Pathol Lab Med

3. SATO S, Yanagisawa T, Miki J, Hayashida Y, et al
   pT1 Subclassification Predicts Progression-Free Survival in En Bloc Resection of Bladder Tumor Specimens.
   Arch Pathol Lab Med. 2024;148:573-580.
   PubMed         Abstract available
   
   

   
   Arch Toxicol

4. XIAO Y, Shen Y, Song H, Gao F, et al
   AKR1C2 genetic variants mediate tobacco carcinogens metabolism involving bladder cancer susceptibility.
   Arch Toxicol. 2024 Apr 25. doi: 10.1007/s00204-024-03737.
   PubMed         Abstract available
   
   

   
   Biochem Genet

5. ZHANG T, Hu B, Xu S, Wang Y, et al
   Association Between CYP24A1 Polymorphisms and Bladder Cancer Risk in the Chinese Han Population.
   Biochem Genet. 2024 Apr 20. doi: 10.1007/s10528-024-10771.
   PubMed         Abstract available
   
   

   
   BJU Int

6. SARI MOTLAGH R, Ghoreifi A, Yanagisawa T, Kawada T, et al
   Surveillance of non-muscle-invasive bladder cancer with blue-light cystoscopy: a meta-analysis.
   BJU Int. 2024 Apr 24. doi: 10.1111/bju.16364.
   PubMed         Abstract available
   
   

   
   BMC Urol

7. PLAGE H, Furlano K, Hofbauer S, Weinberger S, et al
   PD-L1 expression in tumor and inflammatory cells is associated with favorable tumor features and favorable prognosis in muscle-invasive urothelial carcinoma of the bladder not treated by immune checkpoint inhibitors.
   BMC Urol. 2024;24:96.
   PubMed         Abstract available
   
   

   
   Cell Death Dis

8. WANG Y, Nan Y, Ma C, Lu X, et al
   A potential strategy for bladder cancer treatment: inhibiting autophagy to enhance antitumor effects of Nectin-4-MMAE.
   Cell Death Dis. 2024;15:293.
   PubMed         Abstract available
   
   

   
   Cells

9. IBRAHIM OM, Kalinski P
   Breaking Barriers: Modulation of Tumor Microenvironment to Enhance Bacillus Calmette-Guerin Immunotherapy of Bladder Cancer.
   Cells. 2024;13:699.
   PubMed         Abstract available
   
   
10. BARBAUD A, Lascombe I, Pechery A, Arslan S, et al
    GW501516-Mediated Targeting of Tetraspanin 15 Regulates ADAM10-Dependent N-Cadherin Cleavage in Invasive Bladder Cancer Cells.
    Cells. 2024;13:708.
    PubMed         Abstract available
    
    

    
    Curr Issues Mol Biol

11. BILSKI K, Zeber-Lubecka N, Kulecka M, Dabrowska M, et al
    Microbiome Sex-Related Diversity in Non-Muscle-Invasive Urothelial Bladder Cancer.
    Curr Issues Mol Biol. 2024;46:3595-3609.
    PubMed         Abstract available
    
    

    
    Curr Oncol

12. PARRAO D, Lizana N, Saavedra C, Larranaga M, et al
    Active Surveillance in Non-Muscle Invasive Bladder Cancer, the Potential Role of Biomarkers: A Systematic Review.
    Curr Oncol. 2024;31:2201-2220.
    PubMed         Abstract available
    
    

    
    Curr Opin Urol

13. GRAUSENBURGER R, Herek P, Shariat SF, Englinger B, et al
    Recent contributions of single-cell and spatial profiling to the understanding of bladder cancer.
    Curr Opin Urol. 2024 Apr 23. doi: 10.1097/MOU.0000000000001183.
    PubMed         Abstract available
    
    

    
    Cytometry A

14. DUDAIE M, Dotan E, Barnea I, Haifler M, et al
    Detection of bladder cancer cells using quantitative interferometric label-free imaging flow cytometry.
    Cytometry A. 2024 Apr 26. doi: 10.1002/cyto.a.24846.
    PubMed         Abstract available
    
    

    
    Discov Oncol

15. LI DX, Wu RC, Wang J, Yu QX, et al
    An endothelial-related prognostic index for bladder cancer patients.
    Discov Oncol. 2024;15:128.
    PubMed         Abstract available
    
    
16. YANG R, He J, Luo W, Xiang R, et al
    Comprehensive analysis and prognostic assessment of senescence-associated genes in bladder cancer.
    Discov Oncol. 2024;15:130.
    PubMed         Abstract available
    
    

    
    Eur J Nucl Med Mol Imaging

17. UNTERRAINER LM, Eismann L, Lindner S, Gildehaus FJ, et al
    [(68 )Ga]Ga-FAPI-46 PET/CT for locoregional lymph node staging in urothelial carcinoma of the bladder prior to cystectomy: initial experiences from a pilot analysis.
    Eur J Nucl Med Mol Imaging. 2024;51:1786-1789.
    PubMed         Abstract available
    
    

    
    Eur Urol Focus

18. YOUNG M
    The Future of Front-line Metastatic Bladder Cancer is Platinum-free.
    Eur Urol Focus. 2024 Apr 23:S2405-4569(24)00057.
    PubMed         Abstract available
    
    

    
    Eur Urol Oncol

19. PSUTKA SP, Veleber S, Siman J, Holt SK, et al
    Phase 1/2 Randomized Clinical Trial of In-clinic acupuncture Prior to Bacillus Calmette-Guerin in Patients with High-risk Non-muscle-invasive Bladder Cancer.
    Eur Urol Oncol. 2024 Apr 22:S2588-9311(24)00091.
    PubMed         Abstract available
    
    

    
    Exp Cell Res

20. YU XI, He ZIQI, Wang QINGHUA, Ke SHUAI, et al
    Brusatol hinders the progression of bladder cancer by Chac1/Nrf2/SLC7A11 pathway.
    Exp Cell Res. 2024 Apr 23:114053. doi: 10.1016/j.yexcr.2024.114053.
    PubMed         Abstract available
    
    

    
    Front Cell Infect Microbiol

21. LOU K, Chi J, Wu J, Ma J, et al
    Research progress on the microbiota in bladder cancer tumors.
    Front Cell Infect Microbiol. 2024;14:1374944.
    PubMed         Abstract available
    
    

    
    Int Immunopharmacol

22. ZHANG B, Chen P, Zhu J, Lu Y, et al
    The quantity, function and anti-tumor effect of Mucosal associated invariant T cells in patients with bladder cancer.
    Int Immunopharmacol. 2024;133:111892.
    PubMed         Abstract available
    
    

    
    Int J Clin Oncol

23. TAOKA R, Kamada M, Izumi K, Tanimoto R, et al
    Peripheral neuropathy and nerve electrophysiological changes with enfortumab vedotin in patients with advanced urothelial carcinoma: a prospective multicenter cohort study.
    Int J Clin Oncol. 2024;29:602-611.
    PubMed         Abstract available
    
    
24. HASHIMOTO M, Fukuokaya W, Yanagisawa T, Yamamoto S, et al
    Association between comorbidities and survival in patients with metastatic urothelial carcinoma treated with pembrolizumab.
    Int J Clin Oncol. 2024;29:612-619.
    PubMed         Abstract available
    
    
25. GAO Z, Pang Y, Qin X, Li G, et al
    Sarcopenia is associated with leukopenia in urothelial carcinoma patients who receive tislelizumab combined with gemcitabine and cisplatin therapy.
    Int J Clin Oncol. 2024;29:592-601.
    PubMed         Abstract available
    
    

    
    Int J Med Inform

26. SCHWARZ L, Sobania D, Rothlauf F
    On relevant features for the recurrence prediction of urothelial carcinoma of the bladder.
    Int J Med Inform. 2024;186:105414.
    PubMed         Abstract available
    
    

    
    Int J Surg

27. FU S, Shi H, Fan Z, Li J, et al
    Robot-assisted radical cystectomy with intracorporeal urinary diversion: an updated systematic review and meta-analysis of its differential effect on effectiveness and safety.
    Int J Surg. 2024;110:2366-2380.
    PubMed         Abstract available
    
    

    
    Int Med Case Rep J

28. GAO P, Li X, He Z, Zhang H, et al
    Lethal Immune Myocarditis and Myasthenia Gravis Due to Anti-PD-1 Treatment for a Bladder Cancer Patient: A Case Report and Possible Treatment Inspiration.
    Int Med Case Rep J. 2024;17:359-365.
    PubMed         Abstract available
    
    

    
    Int Urogynecol J

29. KOSOVA I, Barsegian V, Gundorova L, Kolbasov D, et al
    PD-L1 Expression in Nonbacterial Chronic Cystitis and Bladder Cancer.
    Int Urogynecol J. 2024 Apr 25. doi: 10.1007/s00192-024-05782.
    PubMed         Abstract available
    
    

    
    J Am Anim Hosp Assoc

30. CHENG WC, Heng HG, Cheng HY, Lin KY, et al
    Findings of an Extraluminal Leiomyosarcoma of the Urinary Bladder in a Dog.
    J Am Anim Hosp Assoc. 2024;60:109-113.
    PubMed         Abstract available
    
    

    
    J Clin Pathol

31. SIVAKUMAAR K, Griffin J, Schofield E, Catto JWF, et al
    Gene of the month: the uroplakins.
    J Clin Pathol. 2024;77:291-296.
    PubMed         Abstract available
    
    

    
    J Clin Transl Sci

32. OHENE-AGYEI J, Madhira M, Smith H, Sardiu ME, et al
    Open or robotic? Radical cystectomies for patients with non-metastatic bladder cancer: A systematic review and meta-analysis.
    J Clin Transl Sci. 2024;8:e57.
    PubMed         Abstract available
    
    

    
    J Med Econ

33. NIEGISCH G, Grimm MO, Hardtstock F, Krieger J, et al
    Healthcare resource utilization and associated costs in patients with metastatic urothelial carcinoma: a real-world analysis using German claims data.
    J Med Econ. 2024;27:531-542.
    PubMed         Abstract available
    
    

    
    J Urol

34. HOLZBEIERLEIN J, Bixler BR, Buckley DI, Chang SS, et al
    Treatment of Non-Metastatic Muscle-Invasive Bladder Cancer: AUA/ASCO/SUO GUIDELINE (2017; Amended 2020, 2024).
    J Urol. 2024 Apr 25:101097JU0000000000003981. doi: 10.1097/JU.0000000000003981.
    PubMed         Abstract available
    
    

    
    Jpn J Clin Oncol

35. OKAWA S, Gatellier L
    Projection of the number of new cases of bladder cancer in the world.
    Jpn J Clin Oncol. 2024 Apr 23:hyae050. doi: 10.1093.
    PubMed        
    
    

    
    Kidney Int

36. ZHANG X, Lian H, Song X, Li J, et al
    Bacillus Calmette-Guerin-induced kidney granulomas.
    Kidney Int. 2024;105:1131.
    PubMed        
    
    

    
    Lasers Surg Med

37. ZLOBINA NV, Budylin GS, Tseregorodtseva PS, Andreeva VA, et al
    In vivo assessment of bladder cancer with diffuse reflectance and fluorescence spectroscopy: A comparative study.
    Lasers Surg Med. 2024 Apr 22. doi: 10.1002/lsm.23788.
    PubMed         Abstract available
    
    

    
    Medicine (Baltimore)

38. OH CH, Cho SB, Lee HJ, Kwon H, et al
    Migration of double-J ureteral stent in patients with ureteroileal anastomosis stricture undergoing radical cystectomy and orthotopic neobladder: Analysis risk factors of stent migration.
    Medicine (Baltimore). 2024;103:e37765.
    PubMed         Abstract available
    
    

    
    Mol Biotechnol

39. ZHANG H, Zhang X, Zhang Y, Han D, et al
    Pan-Cancer Analysis Shows that KIFC2 is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Bladder Cancer.
    Mol Biotechnol. 2024 Apr 24. doi: 10.1007/s12033-024-01149.
    PubMed         Abstract available
    
    

    
    Nat Rev Clin Oncol

40. SIDAWAY P
    A new standard of care for advanced-stage urothelial carcinoma.
    Nat Rev Clin Oncol. 2024;21:336.
    PubMed        
    
    

    
    Nat Rev Urol

41. CZERNIAK B
    Bladder cancer variants - one disease with many faces.
    Nat Rev Urol. 2024 Apr 22. doi: 10.1038/s41585-024-00886.
    PubMed        
    
    

    
    Oncol Lett

42. QIAN J, Zhang Q, Cao Y, Chu X, et al
    Perfusion drugs for non?muscle invasive bladder cancer (Review).
    Oncol Lett. 2024;27:267.
    PubMed         Abstract available
    
    

    
    Res Sq

43. CZERNIAK B, Lee S, Jung SY, Kus P, et al
    Inferring Bladder Cancer Evolution from Mucosal Field Effects by Whole-Organ Spatial Mutational, Proteomic, and Metabolomic Mapping.
    Res Sq [Preprint]. 2024 Apr 10:rs.3.rs-3994376. doi: 10.21203/rs.3.rs-3994376.
    PubMed         Abstract available
    
    

    
    Sci Rep

44. LI J, Wang Z, Wang T
    Machine-learning prediction of a novel diagnostic model using mitochondria-related genes for patients with bladder cancer.
    Sci Rep. 2024;14:9282.
    PubMed         Abstract available
    
    

    
    Small

45. WANG ZQ, Qu TR, Zhang ZS, Zeng FS, et al
    A Transformable Specific-Responsive Peptide for One-Step Synergistic Therapy of Bladder Cancer.
    Small. 2024 Apr 25:e2310416. doi: 10.1002/smll.202310416.
    PubMed         Abstract available
    
    

    
    Technol Cancer Res Treat

46. WU P, Zhao L, Kong G, Song B, et al
    Study on the Role and Mechanism of SLC3A2 in Tumor-Associated Macrophage Polarization and Bladder Cancer Cells Growth.
    Technol Cancer Res Treat. 2024;23:15330338241246649.
    PubMed         Abstract available
    
    

    
    Transl Oncol

47. MA Q, Wu F, Liu X, Zhao C, et al
    20-hydroxyecdysone suppresses bladder cancer progression via inhibiting USP21: A mechanism associated with deubiquitination and degradation of p65.
    Transl Oncol. 2024;45:101958.
    PubMed         Abstract available
    
    

    
    Urol Oncol

48. KASTNER L, Rieger C, Pfister D, Schmautz M, et al
    HIVEC as an alternative option in non-muscle-invasive bladder cancer: Experiences from a high-volume center.
    Urol Oncol. 2024 Apr 22:S1078-1439(24)00340.
    PubMed         Abstract available
    
    
49. GOMEZ DEL CANIZO C, Gonzalez Ginel I, Martin-Arriscado Arroba C, de la Calle Moreno A, et al
    Voided urine cytology is a useful tool predicting non-muscle-invasive bladder cancer risk before surgery.
    Urol Oncol. 2024 Apr 24:S1078-1439(24)00401.
    PubMed         Abstract available
    
    
50. KNORR J, Lone Z, Werneburg G, Adler A, et al
    An exploratory study investigating the impact of the bladder tumor microbiome on Bacillus Calmette Guerin (BCG) response in non-muscle invasive bladder cancer.
    Urol Oncol. 2024 Apr 24:S1078-1439(24)00430.
    PubMed         Abstract available
    
    

    
    Urology

51. CARLTON CE, Christie AL, Prokesch BC, Chao TC, et al
    Robotic simple cystectomy as a last resort for antibiotic-recalcitrant recurrent urinary tract infections in women.
    Urology. 2024 Feb 21:S0090-4295(24)00108-0. doi: 10.1016/j.urology.2024.
    PubMed         Abstract available
    
    
52. HARDESTY JK, Burns RT, Soyster ME, Jansen NE, et al
    Female Bladder Dysfunction Following Boari Bladder Flap Ureteral Reconstruction.
    Urology. 2024;186:31-35.
    PubMed         Abstract available
    
    

    
    World J Urol

53. BEN-DAVID R, Pellegrino F, Alerasool P, Tillu N, et al
    Robotic-assisted radical cystectomy with cutaneous ureterostomies: a contemporary multicenter analysis.
    World J Urol. 2024;42:251.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Bladder Cancer is free of charge.